drugset / Trial / NCT02213224
Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this current study was to assess the therapeutic effects of perindopril and telmisartan for hypertensive patients with NAFLD and make comparison between the therapeutic effects of these two kind of drugs. This study is a randomized parallel control clinical trial which would be carried out in Nanfang Hospital, Southern Medical University. About one hundred and eighty patients would be randomly assigned to perindopril,telmisartan and amlodipine three groups.
Timeline
- Start
- 2014-08
- Primary completion
- 2016-09
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Perindopril | Small molecule | 4 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |